Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
Michalski J, Winter K, Roach M, Markoe A, Sandler HM, Ryu J, et al. Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406. Int J Radiat Oncol Biol Phys. 2012;83:e363–70.
Article PubMed PubMed Central Google Scholar
Michalski JM, Moughan J, Purdy J, Bosch W, Bruner DW, Bahary JP, et al. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial. JAMA Oncol. 2018;4:e180039.
Article PubMed PubMed Central Google Scholar
Kerkmeijer LGW, Groen VH, Pos FJ, Haustermans K, Monninkhof EM, Smeenk RJ, et al. Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial. J Clin Oncol. 2021;39:787–96.
Article CAS PubMed Google Scholar
Shore ND, Moul JW, Pienta KJ, Czernin J, King MT, Freedland SJ. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification. Prostate Cancer Prostatic Dis. 2024;27:192–201.
Morgan TM, Boorjian SA, Buyyounouski MK, Chapin BF, Chen DYT, Cheng HH, et al. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy. J Urol. 2024;211:509–17.
Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. 2021;80:280–92.
Schröder C, Tang H, Lenffer B, Buchali A, Zwahlen DR, Förster R, et al. Re-irradiation to the prostate using stereotactic body radiotherapy (SBRT) after initial definitive radiotherapy - A systematic review and meta-analysis of recent trials. Clin Transl Radiat Oncol. 2024;48:100806.
PubMed PubMed Central Google Scholar
Shen B, Liu J, Wu D, Guo J. Evaluation of the safety and efficacy of high-dose rate brachytherapy for radiorecurrent prostate cancer: a systematic review and meta-analysis. Strahlenther Onkol. 2024;200:655–70. https://doi.org/10.1007/s00066-024-02205-x.
Liu N, Zhou Y, Lee JJ. IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2021;21:111.
Article PubMed PubMed Central Google Scholar
Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72:39.
Article PubMed PubMed Central Google Scholar
Ekanger C, Helle SI, Reisæter L, Hysing LB, Kvåle R, Honoré A, et al. Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up. J Clin Oncol. 2024;42:1934–42.
Article CAS PubMed Google Scholar
Nikitas J, Cao M, Nickols NG, Valle L, Steinberg ML, Kishan AU. Early Safety and Efficacy Profile of Homogeneously Dosed Salvage Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Recurrences After Low Dose Rate (LDR) Brachytherapy. Clin Genitourin Cancer. 2023;21:208–12.
Miszczyk M, Kraszkiewicz M, Moll M, Kaminiów K, Sobel S, Dolla Ł, et al. Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity. Cancers. 2023;15:1180.
Article PubMed PubMed Central Google Scholar
Cozzi S, Finocchi Ghersi S, Bardoscia L, Najafi M, Blandino G, et al. Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes. Strahlenther Onkol. 2023;199:554–64.
Article PubMed PubMed Central Google Scholar
Archer P, Marvaso G, Detti B, Colombo F, Francolini G, Vandendorpe B, et al. Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study. Eur Urol Oncol. 2023;6:303–10.
Allali S, Loap P, Bibault JE, Krepps S, Deforge A, Moreau D, et al. Salvage stereotactic reirradiation for intraprostatic cancer recurrence: A large retrospective study. Prostate. 2023;83:743–50.
Article CAS PubMed Google Scholar
Greco C, Pares O, Pimentel N, Louro V, Nunes B, Kociolek J, et al. Health-related quality of life of salvage prostate reirradiation using stereotactic ablative radiotherapy with urethral-sparing. Front Oncol. 2022;12:984917.
Article CAS PubMed PubMed Central Google Scholar
Francolini G, Loi M, Di Cataldo V, Detti B, Stocchi G, Masi L, et al. Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years. Clin Oncol. 2022;34:50–6.
Perennec T, Vaugier L, Toledano A, Scher N, Thomin A, Pointreau Y, et al. Stereotactic Re-Irradiation for Local Recurrence after Radical Prostatectomy and Radiation Therapy: A Retrospective Multicenter Study. Cancers. 2021;13:4339.
Article PubMed PubMed Central Google Scholar
Matrone F, Revelant A, Fanetti G, Polesel J, Chiovati P, Avanzo M, et al. Partial prostate re-irradiation for the treatment of isolated local recurrence of prostate cancer in patients previously treated with primary external beam radiotherapy: short-term results of a monocentric study. Neoplasma. 2021;68:216–26.
Lewin R, Amit U, Laufer M, Berger R, Dotan Z, Domachevsky L, et al. Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes. Radiat Oncol. 2021;16:114.
Article CAS PubMed PubMed Central Google Scholar
Fuller D, Wurzer J, Shirazi R, Bridge S, Law J, Crabtree T, et al. Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT. Int J Radiat Oncol Biol Phys. 2020;106:291–9.
Article CAS PubMed Google Scholar
Cuccia F, Nicosia L, Mazzola R, Figlia V, Giaj-Levra N, Ricchetti F, et al. Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer. Strahlenther Onkol. 2020;196:628–36.
Bergamin S, Eade T, Kneebone A, Booth J, Hsiao E, Schembri GP, et al. Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer. Int J Radiat Oncol Biol Phys. 2020;108:1172–8.
Pasquier D, Martinage G, Janoray G, Rojas DP, Zerini D, Goupy F, et al. Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUG. Int J Radiat Oncol Biol Phys. 2019;105:727–34.
Article CAS PubMed Google Scholar
Jereczek-Fossa BA, Rojas DP, Zerini D, Fodor C, Viola A, Fanetti G, et al. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT). Br J Radiol. 2019;92:20180494.
D’Agostino GR, Di Brina L, Mancosu P, Franzese C, Iftode C, Franceschini D, et al. Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy. Int J Radiat Oncol Biol Phys. 2019;104:614–21.
Miszczyk L, Stąpór-Fudzińska M, Miszczyk M, Maciejewski B, Tukiendorf A. Salvage CyberKnife-Based Reirradiation of Patients With Recurrent Prostate Cancer: The Single-Center Experience. Technol Cancer Res Treat. 2018;17:1533033818785496.
Article PubMed PubMed Central Google Scholar
Mbeutcha A, Chauveinc L, Bondiau PY, Chand ME, Durand M, Chevallier D, et al. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy. Radiat Oncol. 2017;12:49.
Article PubMed PubMed Central Google Scholar
Loi M, Di Cataldo V, Simontacchi G, Detti B, Bonomo P, Masi L, et
Comments (0)